Pulse Biosciences, Inc. Cost of Revenue
Pulse Biosciences, Inc. (PLSE) reported Cost of Revenue of $273.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-06
- Pulse Biosciences, Inc. cost of revenue for the quarter ending 2026-06-30 was $273.00K.
- Pulse Biosciences, Inc. cost of revenue for the quarter ending 2026-03-31 was $370.00K.
- Pulse Biosciences, Inc. cost of revenue for the quarter ending 2025-12-31 was $260.00K.
- Pulse Biosciences, Inc. cost of revenue for the quarter ending 2025-09-30 was $279.00K.
- Pulse Biosciences, Inc. cost of revenue for fiscal 2025 was $539.00K.
- Pulse Biosciences, Inc. cost of revenue for fiscal 2024 was $0.00.
- Pulse Biosciences, Inc. cost of revenue for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Pulse Biosciences, Inc. cost of revenue for fiscal 2022 was $11.94M, a 506.91% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $273.00K 10-Q · filed 2026-08-06 | $643.00K 10-Q · filed 2026-08-06 | $903.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $370.00K 10-Q · filed 2026-05-14 | $630.00K derived: sum of 2 quarters · filed 2026-05-14 | $909.00K derived: sum of 3 quarters · filed 2026-05-14 | $909.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $539.00K derived: sum of 2 quarters · filed 2026-02-19 | $539.00K derived: sum of 3 quarters · filed 2026-08-06 | $539.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | $279.00K 10-Q · filed 2025-11-05 | $279.00K derived: sum of 2 quarters · filed 2026-08-06 | $279.00K 10-Q · filed 2025-11-05 | $279.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $1.29M derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $1.29M derived: sum of 3 quarters · filed 2024-03-28 | $9.69M derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $1.29M derived: sum of 2 quarters · filed 2024-03-28 | $9.69M derived: sum of 3 quarters · filed 2024-03-28 | $11.04M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $9.69M derived: sum of 2 quarters · filed 2024-03-28 | $11.04M derived: sum of 3 quarters · filed 2024-03-28 | $11.94M 10-K · filed 2024-03-28 |
| 2022-09-30 | $8.40M 10-Q · filed 2023-11-13 | $9.74M derived: sum of 2 quarters · filed 2023-11-13 | $10.65M 10-Q · filed 2023-11-13 | $11.89M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.34M 10-Q · filed 2023-08-10 | $2.25M 10-Q · filed 2023-08-10 | $3.49M derived: sum of 3 quarters · filed 2023-08-10 | $4.22M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $909.00K 10-Q · filed 2023-05-11 | $2.15M derived: sum of 2 quarters · filed 2023-05-11 | $2.88M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.97M derived: sum of 2 quarters · filed 2023-03-31 | $1.97M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $727.00K 10-Q · filed 2022-11-10 | $727.00K 10-Q · filed 2022-11-10 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |